These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 35642793

  • 1. Intestinal Absorption of FITC-Dextrans and Macromolecular Model Drugs in the Rat Intestinal Instillation Model.
    Berg S, Suljovic D, Kärrberg L, Englund M, Bönisch H, Karlberg I, Van Zuydam N, Abrahamsson B, Hugerth AM, Davies N, Bergström CAS.
    Mol Pharm; 2022 Jul 04; 19(7):2564-2572. PubMed ID: 35642793
    [Abstract] [Full Text] [Related]

  • 2. Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.
    Berg S, Kärrberg L, Suljovic D, Seeliger F, Söderberg M, Perez-Alcazar M, Van Zuydam N, Abrahamsson B, Hugerth AM, Davies N, Bergström CAS.
    Mol Pharm; 2022 Jan 03; 19(1):200-212. PubMed ID: 34928160
    [Abstract] [Full Text] [Related]

  • 3. LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies.
    McCartney F, Caisse P, Dumont C, Brayden DJ.
    Int J Pharm; 2024 Aug 15; 661():124353. PubMed ID: 38909926
    [Abstract] [Full Text] [Related]

  • 4. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
    Wang X, Maher S, Brayden DJ.
    Ther Deliv; 2010 Jul 15; 1(1):75-82. PubMed ID: 22816121
    [Abstract] [Full Text] [Related]

  • 5. Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.
    Heade J, Maher S, Bleiel SB, Brayden DJ.
    J Pharm Sci; 2018 Jun 15; 107(6):1648-1655. PubMed ID: 29462634
    [Abstract] [Full Text] [Related]

  • 6. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
    Brayden DJ, Walsh E.
    AAPS J; 2014 Sep 15; 16(5):1064-76. PubMed ID: 24961919
    [Abstract] [Full Text] [Related]

  • 7. In Vivo Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist Peptide.
    Tran H, Aihara E, Mohammed FA, Qu H, Riley A, Su Y, Lai X, Huang S, Aburub A, Chen JJH, Vitale OH, Lao Y, Estwick S, Qi Z, ElSayed MEH.
    Mol Pharm; 2023 Feb 06; 20(2):929-941. PubMed ID: 36592951
    [Abstract] [Full Text] [Related]

  • 8. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
    Brayden DJ, Maher S, Bahar B, Walsh E.
    Eur J Pharm Biopharm; 2015 Aug 06; 94():194-206. PubMed ID: 26026287
    [Abstract] [Full Text] [Related]

  • 9. Evaluation in pig of an intestinal administration device for oral peptide delivery.
    Berg S, Uggla T, Antonsson M, Nunes SF, Englund M, Rosengren L, Fahraj M, Wu X, Govender R, Söderberg M, Janzén D, Van Zuydam N, Hugerth A, Larsson A, Abrahmsén-Alami S, Abrahamsson B, Davies N, Bergström CAS.
    J Control Release; 2023 Jan 06; 353():792-801. PubMed ID: 36493948
    [Abstract] [Full Text] [Related]

  • 10. Enhancing Intestinal Absorption of a Model Macromolecule via the Paracellular Pathway using E-Cadherin Peptides.
    Dening TJ, Siahaan TJ, Hageman MJ.
    J Pharm Sci; 2021 May 06; 110(5):2139-2148. PubMed ID: 33359310
    [Abstract] [Full Text] [Related]

  • 11. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10).
    Twarog C, Liu K, O'Brien PJ, Dawson KA, Fattal E, Illel B, Brayden DJ.
    Eur J Pharm Biopharm; 2020 Jul 06; 152():95-107. PubMed ID: 32387703
    [Abstract] [Full Text] [Related]

  • 12. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G, Barthelmes J, Vetter A, Krieg C, Uhlschmied C, Bonn GK, Bernkop-Schnürch A.
    Drug Deliv; 2011 Aug 06; 18(6):415-23. PubMed ID: 21554106
    [Abstract] [Full Text] [Related]

  • 13. Experiences and Translatability of In Vitro and In Vivo Models to Evaluate Caprate as a Permeation Enhancer.
    Emeh P, Breitholtz K, Berg S, Vedin C, Englund M, Uggla T, Antonsson M, Nunes F, Hilgendorf C, Bergström CAS, Davies N.
    Mol Pharm; 2024 Jan 01; 21(1):313-324. PubMed ID: 38054599
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): Isolated rat intestinal mucosae and sacs.
    Twarog C, McCartney F, Harrison SM, Illel B, Fattal E, Brayden DJ.
    Eur J Pharm Sci; 2021 Mar 01; 158():105685. PubMed ID: 33359131
    [Abstract] [Full Text] [Related]

  • 15. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
    Fein KC, Gleeson JP, Newby AN, Whitehead KA.
    Eur J Pharm Biopharm; 2022 Jan 01; 170():70-76. PubMed ID: 34879228
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
    Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H.
    Eur J Pharm Biopharm; 2006 Jan 01; 62(1):52-8. PubMed ID: 16289777
    [Abstract] [Full Text] [Related]

  • 17. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
    Thanou M, Henderson S, Kydonieus A, Elson C.
    J Control Release; 2007 Feb 12; 117(2):171-8. PubMed ID: 17184870
    [Abstract] [Full Text] [Related]

  • 18. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
    Karavasili C, Spanakis M, Papagiannopoulou D, Vizirianakis IS, Fatouros DG, Koutsopoulos S.
    J Pharm Sci; 2015 Jul 12; 104(7):2304-11. PubMed ID: 25994901
    [Abstract] [Full Text] [Related]

  • 19. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
    Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A.
    Int J Pharm; 2008 Jul 09; 359(1-2):70-8. PubMed ID: 18450395
    [Abstract] [Full Text] [Related]

  • 20. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
    Lindmark T, Schipper N, Lazorová L, de Boer AG, Artursson P.
    J Drug Target; 1998 Jul 09; 5(3):215-23. PubMed ID: 9606011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.